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Abstract: The bacterial family Enterobacteriaceae and fungal genus Candida have continued to be a great 
challenge worldwide including resistance to antibiotics and relapse of infections mediated by them. Among 
these organisms, Salmonella typhi, Shigella species, Klebsiella pneumoniae and Escherichia coli strains have 
emerged as the most frequent cause of diarrheal illnesses which account for an annual mortality rate of 4.6 
million people worldwide and many other infections. Candida albicans has been reported as a causative agent 
of all types of candidiasis. In the present study, the efficacy of plants commonly used plants in Transmara west, 
Kenya against these microbes was investigated. An ethnobotanical survey using semi-structured questionnaire 
was done. Plant extracts were obtained through methanolic extraction. Antimicrobial susceptibility assay was 
done using Kirby Bauer disk diffusion technique. Minimum inhibitory Concentration (MIC), Minimum 
Bactericidal Concentration (MBC) for the bacterial test stains and Minimum Fungicidal Concentration (MFC) 
for C. albicans were determined using microtitre broth dilution method. Phytochemical tests were done using 
standard procedures. The study validates the ethno-medicinal use of Pterolobium stellatum, Rhamnus prinoides, 
Phyllanthus urinaria, Carissa edulis, Clutia abyssinica, Clerodendrum rotundifolium, Clerodendron myricoides 
and Dovyalis abyssinica and recommends consideration for the use of the studied plants as possible sources of 
antimicrobial agents in the development of drugs for treatment of Enterobacteria and Candida related 
infections. 
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I. Introduction 
Salmonella typhi, Shigella dysenteriae, Klebsiella pneumonia and Escherichia coli represent members 
of the Enterobacteriaceae family largely implicated as causes of urinary tract infections (UTIs), many 
bloodstream infections, nosocomial pneumonias, various intra-abdominal infections and diarrhoea [1,2,3]. It is 
estimated that 4 billion diarrheal infections and 4.6 million people, including 2.5 million children deaths occur 
from diarrhea every year particularly in developing countries [4]. According to Sobel (2009) [5], C. albicans is 
the cause of up to about 85–95% of all vulvovaginal candidiasis (VVC). It has been observed that VVC is one of 
the most common vaginal infections with about 50 to 75% women suffering symptomatic disease and 5% 
developing recurring VVC [6]. 
High levels of resistance to commonly used antibiotics have often been recorded among this group of 
bacteria worldwide [7, 8]. In the last two decades, outbreaks of infections caused by extended-spectrum b-
lactamase (ESBL)-producing Enterobacteriaceae have largely been reported [9, 10]. Among other ESBL 
producers, Escherichia coli and Klebsiella pneumoniae have been implicated as the main gram- negative 
bacteria that are associated with production of these enzymes which are responsible for multi-drug resistance 
[11, 12, 13].  
Infection with carbapenemase-producing Enterobacteriaceae is another emerging important challenge 
in health-care settings [14]. A progressive increase in Carbapenem-Resistant Klebsiella pneumoniae (CRKP) 
strain has been observed worldwide over the last decade   posing a great challenge in healthcare settings since 
carbapenem is often used as a drug of last resort in the treatment of diseases caused by resistant bacterial strains 
[15, 16]. Multi-drug resistant (MDR) Salmonella and Shigella disenteriae type 1 strains have also been 
identified and recorded to have escalated into a worldwide problem (17, 18).  
Additionally, many antifungal drugs including imidazoles, triazoles and thiazoles have limitations such 
as a narrow spectrum of action, undesirable side effects, toxicity and emergence of drug resistance [5, 19]. This 
has posed a challenge in the management of Candida infections.  The problem of recurrence of infections 
caused by bacterial and fungal organisms and the emergence of antimicrobial resistance has therefore led to the 
increased interest in herbal products [20]. Plants have been proven to be important both as agents of  
pharmacological research and drug development by acting  as sources of lead compounds for synthesis of drugs 
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or when used directly as therapeutic agents and therefore reducing total dependence on antibiotics [21,22]. The 
objective of our study was to identify some of the plants commonly used against Salmonella typhi, Shigella 
species, Klebsiella pneumoniae, Escherichia coli and Candida albicans by traditional herbal practitioners of the 
Maasai community in Transmara west sub-county, Kenya, investigate their antimicrobial activity in vitro and 
subject them to phytochemical assay to test for presence of saponins, tannins, alkaloids and flavonoids. The 
study site was purposely selected since it is known to be rich in indigenous vegetation and also the use of 
medicinal herbs for treatment of various ailments which is relatively substantial [23].      
 
II. Materials And Methods 
2.1 Ethnobotanical survey 
The study area (Tranamara west sub-county) was divided into six blocks which comprised the six 
divisions in Transmara west namely Kilgoris, Keiyian, Lolgorian, Angata, Pirrar and Kirindon. Key informants 
comprising of Traditional Health Practitioners (THP) knowledgeable on medicinal plants used for treating 
various diseases were identified with the help of local leaders including chiefs and village elders. Selection of 
informants to participate in the study was done using purposive sampling technique [24]. The selection 
depended on the willingness to share information and acquaintance with medicinal plants used for treating 
diseases such as pneumonia, candidiasis and diarrhea. With the help of the local leaders, twelve informants were 
selected by identifying two knowledgeable informants from each of the six divisions.  
Information on medicinal plants used was collected through interviews using a semi-structured 
questionnaire as well as detailed personal discussion with the herbalists [25]. The plants used by the THP in the 
management of diseases whose symptoms were associated with Salmonella typhi, Klebsiella pneumoniae, E. 
coli, Shigella dysenteriae and C. albicans were first identified using their vernacular names. Then the plants 
commonly identified were selected using the ‘species of choice value’ model [26].  
To further select medicinal plants for screening, a participatory pair-wise ranking exercise [27] was 
conducted with confinement to only those plants whose use was restricted to the treatment of typhoid, 
dysentery, pneumonia, diarrhoea and candidiasis. This involved a prioritization exercise involving participation 
of the herbalists.  During the exercise, a list of plants cited in the questionnaire for treatment of fungal and 
enterobacteria related infections was generated. Selection of plants was by agreement of herbalists, whereby 
frequency of use of a given species and comparison between different species used for treatment of the same 
disease were considered. With the guidance of informants, the habitats of the selected plants were located then 
the parts of the plants used in the treatment of the respective diseases, as specified by the informants were 
collected. Voucher specimens were also collected and preserved in a plant press. Identification of the plants was 
done at the Department of Plant and Microbial Sciences in Kenyatta University.  
 
2.2 Collection, identification and drying of plant samples 
After an ethnobotanical survey on plants used by traditional health practitioners in Transmara West 
against the selected pathogens, plant parts, which comprised roots of the sampled plants were collected as 
prescribed by the herbalists and transported for screening at the University. The samples were chopped into 
pieces and air dried in the laboratory for three weeks and then ground into powder using a milling machine and 
stored in sterilized bottles. 
 
2.3 Extraction of chemical substances 
The ground powder was first soaked in methanol for 3 days before decanting and filtering through a Buchner 
funnel using Whatman filter paper No. 42. The filtrate was concentrated using a rotary evaporator (Type N-100, 
SN 60714679, Eyela- Tokyo) with the water bath set at 40 
◦
C. This was followed by drying of the extracts in a 
dessicator over anhydrous Calcium Sulphate [28]. The extracts were then stored at 4 
◦
C for further use [29]. 
 
2.4 Sourcing of test microorganisms 
Clinical isolates of Salmonella typhi, Klebsiella pneumoniae, E. coli, Shigella dysenteriae and C. albicans 
strains were obtained from Kenyatta National Hospital, Kenya, during the period of the assay and transported to 
Kenyatta University for antimicrobial susceptibility testing.  
 
2.5 Antimicrobial susceptibility assay 
Kirby Bauer disk diffusion technique was used [30]. A plant extract concentration of 300 mg/ml was 
prepared using methanol as the solvent. For the test isolates, an inoculum size of 0.5 McFarland standard was 
used. The test bacterial cultures were applied by spreading 0.1 ml of the bacterial inoculums on dry 150 mm 
diameter Mueller-Hinton agar plate [31]. Twelve disks (6 mm diameter) were then soaked in 0.1 ml of the 
dissolved plant extracts. Commercial antibiotic Ciprofloxacin was used as the positive control for the bacterial 
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isolates while methanol was used as a negative control. The disks were then air dried and placed on the 
inoculums’ agar surface separately. Incubation was done for 24hours at 35±2 ◦C before analysis.  
For C. albicans, the disks were soaked in 0.1 ml of the plant extracts, commercial antifungal fluconazole as 
positive control and methanol as negative control. Dry impregnated disks were spread on prepared dry Potato 
Dextrose Agar (PDA) plates containing spread 0.1 ml of C. albicans inoculum. The plates were then incubated 
for 24 hours at 35±2
 ◦
C. Three replicates of the extract and control impregnated disks were made for every test 
microbe. Microbial growth inhibition was determined by measuring the average zones of inhibition to the 
nearest millimeter using a transparent plastic ruler [32]. Based on the size of average zones of inhibition, the 
susceptibility levels by the test pathogens to the crude plant extracts were categorized as resistant (average zone 
of inhibition of ≤ 7.00 mm), intermediately resistant (average zone of inhibition of  between > 7.00 mm and < 
9.00 mm) and susceptible (average zone of inhibition  ≥ 9.00 mm) [28].   
 
2.6 Determination of Minimum inhibitory concentrations (MICs) and Minimum Bactericidal 
      Concentration/Minimum Fungicidal concentrations 
The active extracts which recorded mean zones of inhibition of ≥9 mm from the antimicrobial 
susceptibility test by Kirby Bauer disk diffusion method were tested for MIC and MBC/MFC [33]. The MIC 
was determined by use of Micro-titre broth dilution method [34] using a 96- well micro-titre plate. A solution of 
plant extract (concentration of 300 mg/ml) was prepared using 2% DMSO as solvent [35]. 
All the wells were first filled with fifty microlitres (50 µl) of broth. Fifty microlitres of the prepared 
plant extract solution was then dispensed into the first well then two- fold serial dilutions of 50 µl of broth 
mixed with the extract were carried out until the eleventh well was reached, at which time the last 50 µl was 
discarded [34]. Fifty micro litres (50 µl) of broth containing the standardised test microorganism isolate was 
then dispensed into each well. One well with 50 µl of the antibiotic ciprofloxacin/fluconazole was used as 
positive control while another well without extract or antibiotic was used as the negative control. Incubation was 
done at 37 
◦
C for 24 hours and microbial growth confirmed by visible turbidity. Minimum Inhibitory 
Concentration was represented by the lowest concentration of the extract that prevented visible growth [36]. 
Broth was then taken from each well without visible microbial growth and then sub-cultured onto fresh 
drug-free solid media (Nutrient broth for bacterial isolates and PDA broth for C. albicans) and incubated for 
further 24 hrs. The MBCs and MFCs were defined as the lowest concentrations of the extracts that completely 
killed the inoculated microbial population [34]. 
 
2.7 Test for saponins, tannins, flavonoids and alkaloids 
The plant extracts were subjected to phytochemical screening in order to test for the presence of   saponins, 
tannins, flavonoids and alkaloids [37]. Screening for presence of the selected phytochemicals was carried out 
using standard procedures [38, 39, 40].  
 
2.8 Data analysis 
Data obtained from the zones of inhibition was analyzed using SPSS version 16 computer program. 
The average zones of inhibition values produced by the plant extracts and positive controls in both the bacterial 
and fungal assays were expressed as means ± standard error for each test culture. The effects of the plant 
extracts on the test pathogens were compared by testing for significant difference in the means of zones of 
inhibition using one-way ANOVA at 1% and 5% level of confidence with P value < 0.05 considered as 
significant. The significant means of the zones of inhibition were separated using multiple range test (Tukey 
HSD test).  
 
III. Results 
The ethnobotanical survey carried out in Transmara West, Narok County on the medicinal plants used 
by the local herbalists to treat diseases caused by Salmonella typhi, Shigella dysenteriae, Klebsiella pneumonia, 
Escherichia coli and Candida albicans revealed twenty two plants (Table 4.1). Roots, leaves and stem barks 
comprised the parts commonly used by the herbalists, with roots being the highest preferred and hence chosen 
for the assay. From the species of choice value model, eleven plant species, which were cited by the herbalists 
as the most commonly used by the Maasai Traditional Health practitioners were identified and recorded (Table 
4.1). From these, eight plants were selected for antimicrobial screening after prioritization using participatory 
pair-wise ranking technique (Table 4.2). 
The assay revealed remarkable differences both in the antimicrobial activities as well as the 
phytochemical composition of the plants under study (Table 4.2). The average diameters of zones of inhibition 
produced by the extracts against the test pathogens revealed various susceptibility levels ranging from resistant, 
intermediately resistant as well as susceptible  (Table 4.3). Compared to other extracts whose MICs and MBCs 
were determined against S. typhi, C. abyssinica Jaub and Spach (Euphorbiaceae) had the highest activity with 
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MIC of 18.75 mg/ml and a similar MBC (Table 4.4). Pterolobium stellatum (Forssk.) Brenan (Fabaceae) and 
Carissa edulis (Forssk.) Vahl (Apocynaceae) showed similar MICs and MBCs of 37.50 mg/ml against S. typhi. 
Minimum Inhibitory Concentrations and MBCs of 37.50 mg/ml and 75.00 mg/ml respectively were exhibited by 
both Phyllanthus urinaria Linn (Phyllanthaceae) and Dovyalis abyssinica (A. Rich.) Warb (Flacourtiaceae) 
against the pathogen (Table 4.4).   
The highest activity against E. coli was shown by R. prinoides L’He´r (Rhamnaceae) with MIC and 
MBC of 9.37 mg/ml. Phyllanthus urinaria Linn (Phyllanthaceae) also showed a good activity with MIC and 
MBC of 18.75 mg/ml and 37.50 mg/ml respectively against E. coli with both Clerodendron myricoides 
(Hochst.) Vatke (Verbenaceae) and Dovyalis abyssinica (A. Rich.) Warb (Flacourtiaceae) showing similar MICs 
and MBCs of 37.50 mg/ml. The extracts of both P. stellatum (Forssk.) Brenan (Fabaceae) and P. urinaria Linn 
(Phyllanthaceae) exhibited MICs and MBCs of 37.50 mg/ml and 75.00 mg/ml respectively against E. coli.     
For S. dysenteriae, only two extracts showed promising antibacterial activity and were therefore 
screened for MIC and MBC. Clutia abyssinica Jaub and Spach (Euphorbiaceae) showed a relatively higher 
activity with MIC and MBC of 18.75 mg/ml and 37.50 mg/ml respectively. Phyllanthus urinaria Linn 
(Phyllanthaceae) had MIC of 37.50 mg/ml and MBC of 75.00 mg/ml. The rest of the test extracts were not 
screened for MIC and MBC due to their low activity (zones of inhibition of < 9.0 mm) against S. dysenteriae.  
Against K. pneumoniae, Phyllanthus urinaria Linn (Phyllanthaceae) and Clutia abyssinica Jaub and 
Spach (Euphorbiaceae) showed similar and relatively higher activity with MICs and MBCs of 18.75 mg/ml and 
37.50 mg/ml respectively while Carissa edulis (Forssk.) Vahl (Apocynaceae) and Clerodendron myricoides 
(Hochst.) Vatke (Verbenaceae) both had similar MICs and MBCs of 37.00 mg/ml (Table 4.4).  
For C. albicans, Clutia abyssinica Jaub and Spach (Euphorbiaceae) showed the highest antifungal 
activity with MIC and MFC of 9.37 mg/ml which was close to the MIC and MFC of the positive control (4.69 
mg/ml). Clerodendron myricoides (Hochst.) Vatke (Verbenaceae) also showed good activity with MIC of 9.37 
mg/ml and MFC of 18.75 mg/ml against the fungal pathogen.  
 
IV. Tables 
Table 4.1: Some plant species used by herbalists in Transmara west to treat diseases caused by the test 
pathogens and other related ailments 
Botanical Name Family  Vernacular Name Part used Diseases treated 
Acacia tortilis (Forssk.) Hayne Fabaceae Oltepesi Roots, Stem, 
Leaves 
Urinary tract infections, 
Mouth infections  
Acacia xanthophloea Benth. Fabaceae Olerai Roots, Stem, 
Leaves 
Pneumonia 
Achyranthes aspera L. Amaranthaceae Olerobat Roots, Leaves Candidiasis, Skin 
diseases 
Albizia anthelmintica Brongn. Fabaceae Ormukutan Roots, Stem Stomach ache, 
Diarrhoea, Back ache 
Aloe volkensii Engl. Asphodelaceae Osukuroi Leaves Stomach ache, 
Diarrhoea 
Blepharis linariifolia Pers. Acanthaceae Oltontolian Roots, leaves Pneumonia 
Carissa edulis (Forssk.) Vahl* Apocynaceae Olamuriaki Roots Backaches, 
Kidney problems, 
Pneumonia 
Clerodendron myricoides 
(Hochst.) Vatke* 
Verbenaceae Olmatukutuk Roots Candidiasis, gonorrhoea 
Clerodendrum rotundifolium 
Oliv.* 
Verbenaceae Osingarua Leaves, Roots Pneumonia 
Clutia abyssinica Jaub and 
Spach* 
Euphorbiaceae Olkiparnyeny Roots  Candidiasis 
Commiphora africana (A. Rich.) 
Engl. 
Burseraceae Olchilishili Roots, Stem Skin diseases, 
Candidiasis 
Commiphora sp. Asphodelaceae Oltemuai Roots, Stem Pneumonia, 
Skin diseases 
Crotolaria rotundifolia J.F. 
Gmel.* 
Fabaceae Oloniai Roots Candidiasis 
Dovyalis abyssinica  
(A. Rich.) Warb* 
Flacourtiaceae Olmorogi Roots Typhoid, Diarrhoea 
Echinops sphaerocephalus L.*    Asteraceae Enkomereki Roots, stem,leaves Typhoid 
Melhania 
parvifolia Chiov. 
Malvaceae Orporokwai-
lekop 
Leaves Pneumonia and other 
Lung related Problems 
Phyllanthus urinaria Linn* Phyllanthaceae  Olmenangi Roots, leaves Dysentery, 
Diarrhoea, 
Stomach ache 
Pterolobium stellatum 
(Forssk.) Brenan* 
Fabaceae Kinawa Roots,  
Leaves 
Pneumonia 
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Key: * Plants most commonly used  
 
Table 4.2: Means ± standard error of the mean of zones of inhibition (mm) against the test microorganisms 
Key: The terms a, b, c, d, e, f show significant differences where applicable for the clusters 
 
Table 4.3: Susceptibility levels shown by the test pathogens to the plant extracts and controls as exhibited by 
the means of zones of inhibition produced 
 
 
 
 
 
 
 
 
 
 
Key: R represents Resistant 
          I represents intermediately resistant 
          S represents Susceptible    
          -  represents no inhibition 
 
Table 4.4: MICs and MBCs/MFCs (mg/ml) produced by the medicinal plants and positive controls 
Positive control: Commercial antibiotics Ciprofloxacin (for bacterial isolates) and Fluconazole for (C. albicans) 
- Represents MIC, MBC/MFC not determined due to low activity as revealed by mean zone of inhibition 
of < 9.00 mm 
 
 
 
 
 
 
Rhamnus prinoides L’He´r*  Rhamnaceae Olkonyil Roots, stem Typhoid 
Stomach ache 
Rhynchosia calycosa 
Hemsl.* 
Fabaceae Osaei- Loldia Roots Pneumonia 
Sericocomopsis hildebrandtii 
Schinz. 
Amaranthaceae Olaisai Roots, Leaves Stomach ache, Malaria 
Warburgia salutaris (Bertol.f.) 
Chiov.  
Canellaceae Osokonoi  Roots, Stem Stomach ache,  
Typhoid, Pneumonia 
TREATMENT S. typhi E. coli S. dysenteriae K. pneumaniae C. albican 
Negative controls 6.000 ±0.000a 6.000 ±0.000a  6.000 ±0.000a 6.000±  0.000a 6.000 ±0.000a 
C. rotundifolium   7.667 ±0.333 ab  6.667±0.333ab 8.000± 0.577a 7.333±0.333abc 7.333±0.333ab 
C. myricoides 8.000± 0.577ab 10.667±1.201cd 6.667±0.333a 10.333±0.333bcd 14.000±0.577c 
C. edulis 8.333±0.333ab 7.667±0.333 abc 8.000  ± 0.577a 10.333±1.201bcd 8.000±0.577ab 
D. abyssinica 9.000±0.577 ab 9.667± 0.881abc 7.333± 0.333a 7.000±0.577ab 9.000± .577ab 
P. urinaria 9.667±0.333 bc 13.667± 0.881de 12.000±1.154c 12.667 ± 0.881d 8.000±0.577ab 
P.stellutum 10.000±0.573bc 10.333±1.201bcd 8.667 ±0.881ab  7.333±0.333abc 10.333±0 .881b 
R. prinoides 12.333±0.881 cd 14.667± 0.881e  7.333 ±0 .333a 8.667±0.881abc 6.667±0.333a 
C. abyssinica 14.000±0.577d 9.667±0.881abc 11.667±0.881bc 11.000±1.000cd 14.667±0.333c  
Positive controls 28.333±1.201e 28.667±0 .333f 28.000± 0.577d 29.333±0.881e 24.667±1.201d 
P. value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 
Botanical name of plant S. typhi E. coli  S. dysenteriae K. pneumoniae C. albicans 
P. stellatum (Forssk.) Brenan  S S I I S 
C. edulis (Forssk.) Vahl  I I I S I 
R. prinoides  L’He´r  S S I I R 
P. urinaria  Linn  S S S S I 
C.  abyssinica  Jaub and Spach  S S S S S 
C. rotundifolium  Oliv  I R I I I 
C. myricoides (Hochst.) Vatke  I S R S S 
D. abyssinica (A. Rich.) Warb  S S I I S 
Positive controls S S S S S 
Negative controls - - - - - 
 
     S. typhi 
 
MIC     MBC    
         E. coli 
 
MIC         MBC              
S. dysenteriae 
 
MIC    MBC 
 K. pneumonia 
 
MIC      MBC 
     C. albicans 
   
MIC       MFC 
P. stellatum 37.50    37.50 37.50        75.00   -             -  -              -  37.50     75.00 
C. edulis -             - -                  -   -             - 37.50    37.50   -              - 
R. prinoides 37.50    37.50 9.37           9.37   -             -  -             -    -            - 
P. urinaria 37.50    75.00 18.75        37.50  37.50   75.00  18.75     37.50    -  - 
C. abyssinica 18.75   18.75 37.50        75.00  18.75   37.50    18.75     37.50  9.37       9.37 
C. myricoides -             - 37.50        37.50    -             -  37.50     37.50  9.37      18.75 
D. abyssinica 37.50   75.00 37.50        37.50    -            -    -               -  37.50    75.00 
Positive control 4.69      4.69       2.34            2.34         4.69     4.69   4.69        4.69   4.69      4.69 
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Table 4.5: Phytochemical screening of the extracts from the selected plant species 
Botanical name of plant Tannins Saponins Flavonoids Alkaloids 
Pterolobium stellatum (Forssk.) Brenan 
(Fabaceae) 
+++ ++ +++ - 
Phyllanthus urinaria Linn (Phyllanthaceae) +++ ++ + + 
Clutia abyssinica Jaub and Spach 
(Euphorbiaceae) 
++ + +++ ++ 
Rhamnus prinoides L’He´r (Rhamnaceae) +++ + + +++ 
Clerodendrum rotundifolium Oliv  
(Verbenaceae) 
+++ ++ + - 
Clerodendron myricoides (Hochst.) Vatke 
(Verbenaceae) 
+ - ++ +++ 
Dovyalis abyssinica (A. Rich.) Warb 
(Flacourtiaceae) 
++ ++ - + 
Carissa edulis (Forssk.) Vahl (Apocynaceae) +++ - ++ ++ 
Key: +++ represents high quantity/ abundant 
         ++   represents moderate quantity 
          +    represents low quantity/ trace 
           -    represents absence 
 
V. Discussion 
The use of roots as the most preferred plant parts in the preparation of herbal medicines as revealed in 
the present survey could be because roots are believed to store higher concentrations of phytochemicals than 
other plant parts. Roots have a high partitioning for the photosynthates and exudates [41]. The high 
antimicrobial activity exhibited by Pterolobium stellatum (Forssk.) Brenan (Fabaceae) against S. typhi and E. 
coli may be attributed to the presence of high quantities of tannins and flavonoids in the plant (Table 4.5). These 
compounds have been shown to possess cytotoxic and antidiarrhoeal properties [41].  
In a research conducted by Endale et al. (2014) [42], ethanol extracts from leaves of P. stellatum 
(Forssk.) Brenan (Fabaceae) showed significant in vitro anti-mycobacterial activity against Mycobacterium 
tuberculosis with MIC of 250 mg/ml. Gizachew et al. (2014) [43] revealed that methanol extracts from the roots 
of P. stellatum (Forssk.) Brenan (Fabaceae) showed high activity against S. typhi, Salmonella paratyphi, P. 
aeruginosa, S. aureus and E. coli. Despite the significantly acclaimed antimicrobial value of Carissa edulis 
(Forssk.) Vahl (Apocynaceae) [44, 28, 45], the present study revealed that among the studied pathogens, the 
extracts from the plant were highly active only against K. pneumoniae. The relatively low antimicrobial activity 
of C. edulis (Forssk.) Vahl (Apocynaceae) in the present study may be due to phytochemicals antagonism and 
discrepancies in phytochemical composition as a result of seasonal differences [46]. It could also be as a result 
of intrinsic tolerance of the test microorganisms to the phytochemical combinations in the extracts of the plant 
[47]. Findings of Nedi et al. (2004) [48] show that Carissa edulis (Forssk.) Vahl (Apocynaceae) possesses 
medicinal properties effective in the management of tuberculosis and other ailments. 
Presence of flavonoids in abundance and moderate amounts of tannins and alkaloids (Table 4.5) could 
possibly be contributory to the bacterial and fungal inhibitory nature of extracts from Clutia abyssinica Jaub and 
Spach (Euphorbiaceae) against S. typhi and C. albicans in the present study. This is due to the antibacterial and 
antifungal properties properties that have been attributed to tannins and alkaloids [41]. Methanol extracts of 
Clutia abyssinica Jaub and Spach (Euphorbiaceae) have also been found to possess antiplasmodial properties 
[49]. Resistance against Clerodendron myricoides (Hochst.) Vatke (Verbenaceae) by S. dysenteriae and the low 
inhibition against S. typhi by the plant may be due to phytochemical antagonism [46]. The significant inhibitory 
potency shown by extracts of Clerodendron myricoides (Hochst.) Vatke (Verbenaceae) against E. coli, K. 
pneumonia and C. albicans in this study is comparable to research findings of Aremu et al. (2010) [50] which 
revealed activity of extracts from C. myricoides (Hochst.) Vatke (Verbenaceae) against E. coli, K. pneumoniae 
and C. albicans with MICs of 3.13 mg/ml in all the microbes and MFC of 6.25 mg/ml against C. albicans. 
Resistance towards Clerodendrum rotundifolium Oliv (Verbenaceae) by E. coli despite the high quantities of 
tannins in the plant as revealed in the present assay can be as a result of tolerance towards tannins. It has been 
shown that many strains of bacteria possess tolerance mechanisms towards tannins [34].   
The susceptibility of S. typhi, E. coli, S. dysenteriae and K. pneumonia to Phyllanthus urinaria Linn 
(Phyllanthaceae) could be attributed to synergy among tannins, saponins, flavonoids, alkaloids and other 
phytochemicals that may be present in the plant. This is from the assertion that for many herbal extracts, 
synergy among multiple constituents exists [51]. The large number of pharmacologically active compounds in 
the plant increases the likelihood of interactions taking place [52]. 
The variations in the antimicrobial potency of the plants extracts as revealed by the distinct inhibitory 
zones and the MICs could be as a result of differences in both composition and amount of phytochemicals 
among the plants studied as represented in the present research findings. This is in agreement to Akharaiyi and 
Boboye (2010) [20] who maintain that active medicinal plants, though effective on the microbial isolates tested 
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against may exhibit variations in inhibitory potency resulting from variations in the secondary metabolites 
concentrations in the plants. Variations in the sensitivity may also be attributed to the differences in growth rate 
of the tested organisms, nutritional requirements, temperature and inoculum size [53]. 
 
VI. Conclusion 
The results of the present study revealed that Pterolobium stellatum (Forssk.) Brenan (Fabaceae), 
Rhamnus prinoides L’He´r (Rhamnaceae), Phyllanthus urinaria Linn (Phyllanthaceae), Carissa edulis (Forssk.) 
Vahl (Apocynaceae), Clutia abyssinica Jaub and Spach (Euphorbiaceae), Clerodendrum rotundifolium Oliv 
(Verbenaceae), Clerodendron myricoides (Hochst.) Vatke (Verbenaceae) and Dovyalis abyssinica (A. Rich.) 
Warb (Flacourtiaceae) have a good antimicrobial activities against the studied Enterobacteria and fungal 
pathogens. We therefore recommend for their consideration as possible sources of antimicrobial agents in the 
development of additional drugs for management of Enterobacteria and Candida related infections. Further 
research should be carried out to investigate the safety of direct use of the extracts of the studied plants as 
medicine including their pharmacokinetics and pharmacological activities before their ethno medicinal use is 
validated. 
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